Cargando…

The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

Social anxiety disorder (SAD) is a highly prevalent psychiatric disorder that presents with an early age of onset, chronic disease course, and increased risk of psychiatric comorbidity. Current treatment options for SAD are associated with low response rates, suboptimal efficacy, and possible risk o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Mashal, Boileau, Isabelle, Le Foll, Bernard, Carvalho, Andre F., Kloiber, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2021
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827369/ https://www.ncbi.nlm.nih.gov/pubmed/34468550 http://dx.doi.org/10.1590/1516-4446-2021-1926

Ejemplares similares

Neurochemical Alterations in Social Anxiety Disorder (SAD): A Systematic Review of Proton Magnetic Resonance Spectroscopic Studies
por: Elsaid, Sonja, et al.
Publicado: (2022)

Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder—Preliminary Findings
por: Boachie, Nadia, et al.
Publicado: (2023)

Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
por: Murphy, Thomas, et al.
Publicado: (2020)

Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications
por: Lingegowda, Harshavardhan, et al.
Publicado: (2022)

Endocannabinoid signaling in astrocytes
por: Eraso‐Pichot, Abel, et al.
Publicado: (2022)

Endocannabinoid signaling in glioma
por: Costas‐Insua, Carlos, et al.
Publicado: (2022)

Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies
por: Shyu, Claire, et al.
Publicado: (2022)

Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
por: Gallego-Landin, Ines, et al.
Publicado: (2021)

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013)

Endocannabinoid signaling in synaptic function
por: Noriega‐Prieto, Jose Antonio, et al.
Publicado: (2022)

The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders
por: Maia, J, et al.
Publicado: (2020)

Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders
por: Ahmed, Ishtiaq, et al.
Publicado: (2021)

Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development
por: Le Foll, Bernard, et al.
Publicado: (2014)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
por: Hasbi, Ahmed, et al.
Publicado: (2023)

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
por: Matheson, Justin, et al.
Publicado: (2020)

The endocannabinoid system in anxiety, fear memory and habituation
por: Ruehle, S, et al.
Publicado: (2012)

The endocannabinoid system in modulating fear, anxiety, and stress 
por: Maldonado, Rafael, et al.
Publicado: (2020)

Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
por: Bernal‐Chico, Ana, et al.
Publicado: (2022)

Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
por: Sionov, Ronit Vogt, et al.
Publicado: (2022)

Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders
por: Lester, Kathryn J., et al.
Publicado: (2016)

The influence of conditioned stimuli on [(11)C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence
por: Di Ciano, Patricia, et al.
Publicado: (2021)

Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
por: Zou, Mingyang, et al.
Publicado: (2021)

Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients
por: Ambrożewicz, Ewa, et al.
Publicado: (2018)

A review of systems biology research of anxiety disorders
por: Mufford, Mary S., et al.
Publicado: (2020)

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies
por: Duncan, R. Scott, et al.
Publicado: (2023)

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [(11)C]-(+)-PHNO study
por: Chukwueke, Chidera C., et al.
Publicado: (2021)

The Pathophysiology of Moyamoya Disease: An Update
por: Bang, Oh Young, et al.
Publicado: (2016)

Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges
por: Koyuncu, Ahmet, et al.
Publicado: (2019)

Social Anxiety Disorder: Associated Conditions and Therapeutic Approaches
por: Alomari, Nasser A, et al.
Publicado: (2022)

Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches
por: Kosel, Markus, et al.
Publicado: (2022)

The Endocannabinoid System May Modulate Sleep Disorders in Aging
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2020)

Possible roles of amyloids in malaria pathophysiology
por: Moles, Ernest, et al.
Publicado: (2015)

The pathophysiology of excess plasma-free cholesterol
por: Gillard, Baiba K., et al.
Publicado: (2023)

The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

The Endocannabinoid System as a Therapeutic Target in Glaucoma
por: Cairns, Elizabeth A., et al.
Publicado: (2016)

Therapeutic Opportunities through the Modulation of Endocannabinoid Transport
por: Guo, Jason J, et al.
Publicado: (2013)

The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: A report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders
por: Meissner, Mark H., et al.
Publicado: (2021)

Psychosocial and pharmacological interventions for the treatment of cannabis use disorder
por: Sabioni, Pamela, et al.
Publicado: (2018)

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
por: Charytoniuk, Tomasz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qc51ohq4htt4ilv2aqk2im2k8a